AJP - Heart and Circulatory Physiology, Vol 256, Issue 2 560-H566, Copyright © 1989 by American Physiological Society

ARTICLES

Effects of ATP precursors on ATP and free ADP content and functional recovery of postischemic hearts

G. Ambrosio, W. E. Jacobus, M. C. Mitchell, M. R. Litt and L. C. Becker
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

It has been proposed that administration of adenine nucleotide precursors might accelerate replenishment of myocardial ATP and "free" ADP, thus improving recovery of depressed contractility of postischemic hearts. To test this hypothesis, Langendorff-perfused rabbit hearts were subjected to 20 min of global ischemia and reperfused for 2 h with normal perfusate (n = 8) or perfusate containing 100 mumol/l of the ATP precursors adenosine (n = 8) or 5-amino-4-imidazolecarboxamide riboside (AICAriboside; n = 8). After reperfusion, developed pressure in untreated hearts averaged 70-80% of base line, whereas ATP content was reduced to approximately 70% of preischemic values. AICAriboside administration did not increase tissue ATP levels or contractility. However, in every heart that received adenosine during reperfusion, ATP content increased from a mean value of 65 +/- 4% of base line to 84 +/- 5% at the end of reperfusion (P less than 0.001). Free ADP also increased in adenosine-treated hearts from 40 to 50% of base line at the beginning of reperfusion, to normal levels by 60 min. However, no improvement in contractility was observed in the hearts that received adenosine. These results support the hypothesis that decreased availability of nucleotide precursors is responsible for depressed ATP levels in postischemic hearts; however, reduced ATP and free ADP levels may not be directly responsible for the depressed function of stunned myocardium.

This article has been cited by other articles:

				Y. Chung Oxygen reperfusion is limited in the postischemic hypertrophic myocardium Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2075 - H2084. [Abstract] [Full Text] [PDF]

				R. A. Kloner and R. B. Jennings Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1 Circulation, December 11, 2001; 104(24): 2981 - 2989. [Abstract] [Full Text] [PDF]

				R. Bolli and E. Marban Molecular and Cellular Mechanisms of Myocardial Stunning Physiol Rev, April 1, 1999; 79(2): 609 - 634. [Abstract] [Full Text] [PDF]

				R. D. Lasley and R. M. Mentzer Jr. Dose-Dependent Effects of Adenosine on Interstitial Fluid Adenosine and Postischemic Function in the Isolated Rat Heart J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 806 - 811. [Abstract] [Full Text]

				J. A. Crestanello, J. Kamelgard, D. M. Lingle, S. A. Mortensen, M. Rhode, and G. J. R. Whitman ELUCIDATION OF A TRIPARTITE MECHANISM UNDERLYING THE IMPROVEMENT IN CARDIAC TOLERANCE TO ISCHEMIA BY COENZYME Q10 PRETREATMENT J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 443 - 450. [Abstract] [Full Text]

				M. P. S. Randhawa Jr., R. D. Lasley, and R. M. Mentzer Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 63 - 74. [Abstract] [Full Text]

				R. D. Lasley and R. M. Mentzer Jr. The role of adenosine in extended myocardial preservation with the University of Wisconsin solution J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1356 - 1363. [Abstract] [Full Text]